Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News....
FOOTHILLS EXPLORATION INC. ENTERS AGREEMENTS TO REWORK AND DRILL A NEW WELL IN THE ILLINOIS BASIN
Today 8:00 AM ET (GlobeNewswire)
Foothills Exploration, Inc. (OTC: FTXP), including its direct and indirect subsidiaries, ("Foothills," or the "Company"), an oil and gas exploration company, is pleased to announce that has entered into a participation agreement with an Illinois basin operator.
The Company, through its direct subsidiary, Anaconda Energy, LLC, has entered in to a participation agreement with Benchmark Properties, Ltd. to develop the Ste Marie West Prospect in Jasper County, Illinois, and to acquire fifty-percent (50%) working interest in the Sears-Houser #4 well in exchange for paying fifty-percent (50%) of the total rework and recompletion costs for the subject well with the objective of a recompletion in the Aux Vase Sand (2,719-2,730). The parties have also identified a multi-stacked pay location on the Ste Marie Prospect to drill to 3,500 feet with the primary objective of the McClosky Limestone.
"We are looking forward to working with our partner to identify other recompletion and infield drilling opportunities in the Basin," said Alex Hemb, CEO of Anaconda Energy, LLC and Director of Foothills Exploration, Inc.
This partnership will utilize the talents of a Petroleum Geologist with 40 plus years' experience in exploitation and exploration in the Illinois Basin. Furthermore, Benchmark Properties, Ltd has been drilling and operating successful oil leases in the Illinois Basin since 1995.
"A key platform of our Illinois basin strategy is identifying inactive wells that can be returned to production for minimal costs," said Hemb. "We are actively looking for rework and recompletion candidates that fit these criteria," continued Hemb.
Illinois Basin
The Illinois Basin began commercial oil production in 1905 and the Clay City Consolidated field where the Ste Marie prospect exists has produced over 363 million barrels of oil (MMBO) since 1932. There are approximately 32,100 oil and gas production wells, 10,500 Class II injection wells and 1,750 gas storage wells in Illinois.
About the Company
Foothills Exploration, Inc. ("FTXP" or the "Company"), is an oil and gas exploration and development company focused on delivering the energy needs of today and tomorrow. The Company's strategy is to build a balanced portfolio of assets through two core initiatives. The first initiative is to generate high-impact oil and gas exploration projects. The second is to invest in hydrogen and geothermal projects for a low carbon future through its New Energy Ventures division by identifying areas where the Company can contribute to a viable, realistic, and balanced future energy mix. For additional information please visit the Company's website at www.foothillspetro.com.
Forward-Looking Statements
All statements, other than statements of historical facts, included in this release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements. These statements are based on certain assumptions we made based on management's experience, perception of historical trends and technical analyses, current conditions, capital plans, drilling plans, production expectations, our ability to raise adequate additional capital, or enter into other financing arrangements to support our acquisition, development and drilling activities, anticipated future developments, and other factors believed to be appropriate and reasonable by management. When used in this release, words such as "will," "possible," "potential," "believe," "estimate," "intend," "expect," "may," "should," "anticipate," "could," "plan," "predict," "project," "profile," "model," "strategy," "future" or their negatives or the statements that include these words or other words that convey the uncertainty of future events or outcomes, are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. In particular, statements, express or implied, concerning our future operating results and returns or our ability to acquire or develop proven or probable reserves, our ability to replace or increase reserves, increase production, or generate income or cash flows are forward-looking statements.
BREAKING NEWS:
Analyst Reports
Search News
By symbol
Enter symbol...
Search
Article Tools
Set News Alert
Companies Mentioned
Symbol Last Change
VYST $0.0257 0.00%
Back to News Overview
Vystar Posts Highest Revenue & Profit in Company History in First Quarter 2021
Today 8:30 AM ET (GlobeNewswire)Print
Vystar Corporation (OTCQB: VYST) reports milestone financial results for the first quarter of 2021 with record high revenue and profit for the first time in the company's history. Revenue for the three months ended March 31, 2021 and 2020 were $12,868,119 and $5,932,238, respectively, for an increase of $6,935,881 or 117%.
"The increase in revenues was due to three factors: 1) the high impact 'Closing to Remodel' sale event at Rotmans Furniture and Flooring that surpassed every quarter in Rotmans 50+ year history, 2) an increase in sales of RxAir UV light air purification units which destroy a broad array of airborne viruses, bacteria and other pathogens, and 3) the PPP forgivable government loan to help re-opening," Steve Rotman, Vystar CEO, stated. "The COVID pandemic has increased commercial and consumer demand for RxAir units as they seek solutions to reduce airborne viruses. Vystar's revenues in the first quarter of 2020 were negatively impacted as COVID caused store traffic to decrease then shut down. We've emerged stronger than ever with multiple revenue streams, promising new product developments and a greatly enhanced cash balance sheet."
The Company reported a significant increase in gross profit to $6,791,279 for the three-month period ended March 31, 2021 compared to gross profit of $2,999,624 for the three-month period ended March 31, 2020, an increase of $3,791,655 or 126%. The increase in gross profit was primarily due to a change in purchasing which started when the store reopened in May 2020 and the reduction of special offers. Merchandise is now being purchased in large quantities from fewer vendors.
The first quarter 2021 results also include the sales margins of a significant number of RxAir units. Deliveries on the backlog of orders for RxAir units restarted in December 2020 and continued in Q1 2021 coupled with current new orders. The backlog was a result of the Company taking advance orders for RxAir units while simultaneously spending the summer and fall of 2020 rebuilding its supply chain and contracting with a new manufacturer amid the pandemic-induced supply shortages and the manufacturing and shipping slowdowns worldwide.
The Company's operating expenses were $5,820,622 and $3,850,177 for the three months ended March 31, 2021 and 2020, respectively, an increase of $1,970,445 or 51%. The increase was due in part to fees incurred under an agreement with a third-party agent to assist the Company with the high-impact "Closing to Remodel" sale at Rotmans, as well as increased advertising expenses.
Net income (loss) was $918,127 and ($1,367,377) for the three months ended March 31, 2021 and 2020, respectively, an increase of $2,285,504 or 167%. Net income in the quarter ended March 31, 2021 versus net loss in the same period in 2020 was due to increased sales and margins from Rotmans operations, increased sales of RxAir, and the PPP loan forgiveness.
The RxAir product line includes the following items that have achieved FDA clearance as Class II Medical Devices:
-- RX400 Filterless Air Purifier
-- RX3000 Commercial Air Purifier
Vystar sells RxAir residential and commercial units through multiple distributors and the Company's website. Once distribution channels are firmly established, Vystar expects the air purification products will produce margins of up to 70%. Vystar has been contracted by numerous school districts and state education departments to supply units on a broad scale and is working on expanding its RxAir offerings including private labeling.
Mr. Rotman noted, "Vystar expects the RxAir unit volume to grow through the rest of 2021 as school districts, government agencies, churches, healthcare facilities, gyms and commercial entities re-open to normal levels. Many schools have indicated they are concerned about improving air quality overall, not just to reduce pandemic risk. With the ongoing emergence of COVID-19 variants and other viruses, and increasing awareness of how air quality affects general health, Vystar will continue to educate consumers about the benefits of RxAir and has robust manufacturing capabilities that can adjust production to meet demand."
Vytex is a multi-patented latex raw material in which the allergy causing proteins are reduced to a level that falls at or below detection based on ASTM approved test methods. Vytex has been available as a raw material commercially for ten years and has a dedicated group of manufacturers who use it in end products such as electrical gloves, condoms, adhesives, etc. Ironically, most use Vytex for its many properties that make it a superior performing, more durable and stronger latex raw material rather than its protein properties.
Vystar's Market Development and Distribution Agreement with Corrie MacColl, Ltd. (CMC Global) to expand the market for Vytex natural rubber liquid latex and the newly developed dry rubber has garnered much attention across a broad range of industries.
"We are excited to have Vytex in front of CMC Global's broad audience via their well-established sales and distribution network," Mr. Rotman stated. "As CMC Global's Cameroon plantations and processing facilities resume production now after the annual winter shut down, Vytex will be produced there on a semi-exclusive basis, providing a reliable supply for customers."
As of mid-2020, Vystar and the Indian Rubber Manufacturers Research Association's (IRMRA) have been actively collaborating to develop viscoelastic deproteinized natural rubber (DPNR) variants having properties for expanding applications in specific new arenas such as green tires, biodegradable and other unique bioelastoplast product lines.
"Our Vytex R & D test partners in India are extremely enthusiastic about our new developments in the dry rubber and latex areas that are applicable for multiple industries," stated William Doyle, former Vystar CEO and current Vytex Product Development Advisor. "We are looking forward to sharing these results with a broader audience this this summer. While the pandemic has halted much activity in India, fortunately we are able to share information virtually and continue our progress."
For the full Q1 2021 Financials, visit www.sec.gov.
For more information on our products, contact info@vytex.com or 508-791-9114, visit www.Vytex.com, www.Rxair.com, www.Rotmans.com, or www.VystarCorp.com or follow us on social media:
Twitter: @VystarCompany @RxAir
Facebook: @RxAir
Instagram: @rxair_air_purification
# # #
About Vystar Corporation:
Based in Worcester, Mass., Vystar Corp. (OTCQB: VYST) is the majority owner of Rotmans Furniture and Flooring and environmentally friendly technologies and products to improve lives, including RxAir UV light air purification products that destroy harmful airborne viruses and pathogens, Vytex Natural Rubber Latex (NRL), and Fluid Energy Solutions. Vytex is a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex for a stronger, more durable, yet environmentally safe, "green" and fully biodegradable product that can be used in a broad range of consumer and medical products. For more information, visit www.vystarcorp.com.
Contacts:
Media: Julie Shepherd, Accentuate PR, 847_275_3643, Julie@accentuatepr.com
Investors: Lee Howley, lhowley@vytex.com, 508_791_9114
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
https://ml.globenewswire.com/media/c0bd94cb-125c-476e-8700-c217806c51d5/small/company-logo-jpg.jpg
https://ml.globenewswire.com/media/c0bd94cb-125c-476e-8700-c217806c51d5/small/company-logo-jpg.jpg
COMTEX_387171984/2010/2021-05-24T08:30:00
NEWS:
Medolife Rx Implements Proprietary Electro Solution, Further Increasing Efficacy of Polarization Technology
5/6/21 8:53 AM ET (GlobeNewswire)Print
via NewMediaWire ÃĢ?' Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it has successfully implemented a new technology into its polarization methodology that further increases the effect of polarization, where it increases efficacy and potency of active pharmaceutical ingredients (APIs) for use in pharmaceutical and nutraceutical products.
Proprietary to the Company, the original polarization technology was developed by Medolife CEO Dr. Arthur Mikaelian and increases the potency of single molecules and complex compounds. The polarization process leverages quantum biology with the goal of creating a resonating effect. In order to achieve this, scientists need molecules at very high frequencies. Generating these high frequencies is commonly done through harmonics; however, in order to generate frequencies at the levels needed to achieve resonance, the use of harmonics tends to generate a large amount of heat. The new process designed by Dr. Mikaelian leverages electromagnetics of A/C and D/C currents in order to achieve the frequencies needed, with little heat. Additionally, with the increased spectrum of frequencies now possible, the company is able to increase the efficacy of its polarization technique and redirect resources previously needed to manage the high heat.
"Science is about constant improvement, and we achieved a very tangible example of that in this case," Dr. Mikaelian said. "While our polarization methodology is patented and efficacious, we are working on a new scientific approach, and that provides us the opportunity to identify inefficiencies and make changes to improve them. In this case, we took a very successful process and made it even better. This further illustrates to me that we have so much more room for scientific breakthroughs in the work we are doing, even beyond our proven approach to polarization."
Medolife leverages this polarization technology in both its nutraceutical consumer wellness products as well as in its pharmaceutical drug candidates, where the Company is conducting clinical trials in the areas of the SARS-CoV-2 (COVID-19) virus and various forms of cancer. The Company's lead product is Escozine(R), a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company's polarization technology. The Company has recently announced many milestones in its pharmaceutical programs, culminated in its first major drug product registration in the Dominican Republic (DR), allowing for sales of Escozine(R) throughout Latin America.
Furthermore, the Company will continue to operate in the nutraceutical space with consumer products in general wellness, stress relief, anxiety treatment, and pain management.
About Medolife Rx
Medolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products. Medolife Rx was created through the merger of Medolife, a private company founded by Dr. Arthur Mikaelian who pioneered the unlaying polarization technology that makes the Company's portfolio of pharmaceutical and nutraceutical products so effective, and Quanta, Inc., a direct-to-consumer wellness product portfolio company. The Company's lead clinical development programs include Escozine(R), a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company's polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. The Company has completed preclinical safety and efficacy research on Escozine(R) and is pursuing product registration and drug approval in various countries, including the United States and throughout Latin America.
Through its subsidiary QuantRx, Medolife manufactures and distributes consumer wellness products in high-impact consumer areas such as pain relief, beauty, and general wellness. QuantRx products are designed using Dr. Mikaelian's polarization technology, which applies advances in quantum biology to increase the potency of active ingredients. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste, and facilitate healthier, more sustainable consumption.
Beyond its own clinical and consumer applications, the polarization technology used by Medolife and its subsidiaries has many potential applications. From potentiating bio-ingredients, to producing more effective carbon-trapping plants, to transformative anti-aging solutions, Medolife has the opportunity to upend how commercial and pharmaceutical products are made and increase their benefits, while decreasing their chemical concentration.
Forward-Looking Statements
Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management including statements regarding the Company's expected results of operations or liquidity; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance; and statements of management's goals and objectives and other similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "we believe," "we intend," "may," "will," "should," "could," and similar expressions. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.
Contacts:
Tom Nelson
https://ir.quantrx.com/
818-659-8052
Kyle Porter
NEWS:....
TPT Global Tech's Subsidiary TPT MedTech to Provide Turnkey Testing Technology for Anticipated First "Covid-19 Free" Full Attendee Concert of Summer 2021 Utilizing Company's QuiKLAB(TM) "Check and Verify" Passport Testing and Monitoring Platform
3/4/21 10:31 AM ET (Accesswire)Print
In its first demonstration of the value of its Events.com partnership, the company is sponsoring, along with Levert Entertainment, Skyboxx Empire, and the Tunica County Mississippi Chamber of Commerce, a Nationally-Streamed Juneteenth Concert Event
SAN DIEGO, CA / ACCESSWIRE / March 4, 2021 / TPT Global Tech Inc. (OTCQB:TPTW) www.tptglobaltech.com based in San Diego, California, a technology-based company with divisions providing telecommunications, medical technology, media content for domestic and international syndication as well as technology solutions, today announced that on June 18th and 19th its TPT MedTech subsidiary, www.tptmedtech.com and the Tunica County Mississippi Chamber of Commerce will partner to hold what is anticipated to be the first full attendance concert in the region and one of the first in the country.The full slate of artists scheduled to perform for the Juneteenth event will be released shortly.
TPT MedTech, through its recently signed agreement with Events.com, has been working with the Chamber and its Experience Tunica County initiative to help restore and revitalize the county's casino and tourism industry. The company is also considering locating one of its Mobile QuikLAB manufacturing facilities in Tunica as part of the Chamber's overall revitalization and economic recovery efforts to bring jobs to the region and diversify the local economy.
The Tunica River Park's venues, located right on the Mississippi River, hold up to 17,000 people in the open air facility and up to 2000 patrons at the indoor facility, respectively. The estimated 2000 indoor, two-day VIP tickets are $150 each and the general attendance tickets for Saturday only are $80. Both tickets include the cost of the TPT Covid test. All attendees will be Covid tested through TPT MedTech's all-in-one MobileQuikLAB facility using the company's QuikPASS Check and Verify technology platform. Patrons will be required to log on to the QuikLAB webapp (www.thequiklab.com) enter their name and drive up to the company's Mobile QuikLABS to be Covid tested in order to gain access to the River Front events. The rapid test will provide results in15 minutes via the QuiKPASS Check and Verify webapp passport.
"We are committed to helping communities across the country get back to normal and what we are doing with this partnership will truly demonstrate we can achieve our safe testing, privacy and security goals on a large scale," said CEO Stephen J. Thomas III. "We are pleased to get our relationship with Events.com underway with this concert and confident our technology platforms will prove to be a great weapon and huge asset as we continue to fight Covid 19 at home and internationally."
As an innovative technology company, TPT recognizes that addressing the Covid-19 pandemic requires a combination of technology and medical solutions. With the onset of the pandemic, the company immediately pivoted into the medical sector launching its TPT MedTech division www.tptmedtech.com. TPT MedTech's core product lines include its "QuikLABT", "QuikPASST" and "SaniQUIKT" solutions. Together they provide "End to End", turnkey and streamlined COVID-19 testing and verifying technology platforms with, 1. Scalable, mobile, on-site medical-grade labs that come to offices/venues, etc. to conduct testing, 2. A fully online, private and secure HIPAA Compliant webapp to share when a customer needs to provide proof that they've tested negative/positive and/or if they've been vaccinated, and, 3. Mobile sanitizing cabins (organic/safe, takes 240 people/hour with a 1-second thermal scan) to ensure that an individual is not carrying the virus on the exterior of their clothing.
The company believes that countries as a whole need to do more testing, but once that testing is complete there remains a need for a centralized platform to securely display that testing information so that all citizens can prove their testing results, in real-time, to any establishment requiring it for entry. The "QuikPass" Check and Verify and Vaccination monitoring passport was developed to validate that information in real-time giving all Federal and State Government agencies, transportation companies, schools, airlines, hospitals, sports venues, restaurants, hotels and nightclubs the ability to check and verify if an individual has been tested for Covid 19 or vaccinated. The company also believes it is essential to note that its "QuikPASS" Check and Verify Passport will be distributed FREE in the United States.
The company currently has three national partnerships. It is working with Events.com for concerts and corporate events and Wal-Mart to place its "QuikLABs" in Wal-Mart parking lots across the United States. Its other strategic partnership is with Thomas Scientific-Hook Laboratories for high thru-put PCR testing across the US in its Mobile "QuikLABS". To date, the company has three working QuikLAB locations, two in Wal-Mart stores in Miami and one "QuikLAB" at the Dadeland Mall also in Miami. The company is also on-boarding Co-labs and Pharmacies onto it's "QuikLAB" and "QuikPASS" platforms starting on the East Coast and working West. In the travel sector, the company is on-boarding testing sites at two international airports in Jamaica, Montego Bay and Kingston where it anticipates testing 3000-5000 travelers per day when fully operational.
About TPT Global Tech
TPT Global Tech Inc. (TPTW) based in San Diego, California, is a technology-based company with divisions providing telecommunications, medical technology and product distribution, media content for domestic and international syndication as well as technology solutions. TPT Global Tech offers Software as a Service (SaaS), Technology Platform as a Service (PAAS), Cloud-based Unified Communication as a Service (UCaaS). It offers carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT's cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media and collaboration features in today's global technology markets. TPT Global Tech also operates as a Master Distributor for Nationwide Mobile Virtual Network Operators (MVNO) and Independent Sales Organization (ISO) as a Master Distributor for Pre-Paid Cell phone services, Mobile phones Cell phone Accessories and Global Roaming Cell phones.
Contact:Shep Doniger 561-637-5750 sdoniger@bdcginc.comFrank Benedetto 619-915-9422
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.
SOURCE: TPT Global Tech, Inc.
View source version on accesswire.com: https://www.accesswire.com/633506/TPT-Global-Techs-Subsidiary-TPT-MedTech-to-Provide-Turnkey-Testing-Technology-for-Anticipated-First-Covid-19-Free-Full-Attendee-Concert-of-Summer-2021-Utilizing-Companys-QuiKLABTM-Check-and-Verify-Passport-Testing-and-Monitoring-Platform
I also hope the talk with "Biden Administration" go through. I have 1M shares that I am holding too NOT as much as you guy have, but I am happy to what I got.
However, If it does not go through tell TPTW to talk to the US Military as well. They are in control of the situation right now, since, January 20, 2021.
Sorry my friend. I have been living back here in the Philippine Island (other side of the world) after I retire from work 5 years ago. Since, I am away from the mainland (Long Dist. USA) I find it very difficult to do any DD regarding potential stocks to acquire, especially, when our location - time difference is about 12 hours (Day & Night) from the mainland USA.
In other words, I have no opinion about TPTW' possible government contract Agreement whether they allocate medical testing equipment or not.
Best of luck to all of us. Go TPTW!!!
NEWS:
https://finance.yahoo.com/news/tpt-global-tech-otcqb-tptw-185000190.html
TPT Global Tech’s (OTCQB:TPTW) Subsidiary TPT MedTech and its Distributor AllStar Health Brands Complete a $338k Transaction with Baywest Wellness Ltd Hospital and Clinics to Launch Its "QuikLAB" Testing and "QuikPASS" Check and Verify Passport in the Country of Jamaica
Tue, January 26, 2021, 7:50 PM
"We continue to expand our network to assist in the management of the COVID-19 crisis."
SAN DIEGO, CA / ACCESSWIRE / January 26, 2021 / TPT Global Tech, Inc. www.tptglobaltech.com ("TPTW or the Company") (OTCBB:TPTW) announced today that it's subsidiary TPT MedTech www.tptmedtech.com and one of its Distributors AllStar Health Brands a Canadian vitamin distribution company www.allstarhealthbrands.com concluded its first $338,000 financial transaction. Baywest Wellness www.baywestwellnesshospital.com one of Jamaica's largest Hospitals and Point of Care clinics purchased PCR testing equipment, PCR tests, and a Software as a Service (SaaS) licensing agreement from TPT MedTech. Baywest Wellness will also operate and market TPT MedTech "QuikLAB" and "QuikPASS" technology platforms as a co-branding partner to Hotel Resorts, Business and Government Agencies in Jamaica. TPT MedTech and AllStar Health Brands will supply Baywest Wellness with monthly COVID-19 testing supplies and Baywest Wellness will pay TPT Med Tech a per test transaction fee to operate on TPT MedTech's "QuikLAB" and "QuikPASS" check and Verify Passport platforms. The companies anticipate that it will take approximately 2 to 3 weeks to deliver the PCR Testing equipment to Jamaica and complete the software onboarding and training activities. TPT MedTech, AllStar Health Brands, and Baywest Wellness have a target Jamaica launch date for the middle of February 2021.
TPT MedTech developed its "QuikPass" Check and Verify passport system and COVID-19 19/Vaccination monitoring platform for corporations, government organizations, schools, airlines, hospitals, sports venues, restaurants, hotels, and nightclubs to check and verify that an individual has been tested for COVID-19 19 or vaccinated providing proof individuals are virus-free and able to gain access to venues with the idea that everyone inside that venue would be COVID-19 free. The "QuikPass" Check and Verify passport-style platform works with third-party testing labs and organizations that participate in the "QuikPass" Network and will be offered FREE to US domestic and international business commerce and government organizations around the world.
"We are very pleased with AllStar and how hard they are working to help distribute our TPT MedTech's products around the world," said Stephen Thomas, CEO.
About TPT Global Tech
TPT Global Tech Inc. (TPTW) based in San Diego, California, is a technology-based company with divisions providing telecommunications, medical technology and product distribution, media content for domestic and international syndication as well as technology solutions. TPT Global Tech offers Software as a Service (SaaS), Technology Platform as a Service (PAAS), Cloud-based Unified Communication as a Service (UCaaS). It offers carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT's cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media and collaboration features in today's global technology markets. TPT Global Tech also operates as a Master Distributor for Nationwide Mobile Virtual Network Operators (MVNO) and Independent Sales Organization (ISO) as a Master Distributor for Pre-Paid Cell phone services, Mobile phones Cell phone Accessories and Global Roaming Cell phones.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.
CONTACT:
Frank Benedetto
619-915-9422
SOURCE: TPT Global Tech, Inc.
QUOTE:
TPTW has been talking to HomeLand Security and FEMA for a while... But with the government in limbo I think politics got in the way of awarding some of these contracts.
Trump conceded and noted a new administration would be coming in. I think the reality is Trump will leave office on Jan 20 and Biden will come in. We shall see
***********************************************************************
I think you misunderstood what President Trump said. He never conceded. I believe he said... (paraphrasing since I don't have the actual quote right now)) There will be a smooth transition of a "new administration".... meaning... new administration of his re-election - new VP and some Cabinet Members etc.
IT REMAINS TO BE SEEN THOUGH, OF COURSE.... GOOD LUCK!!!
I would strongly suggest to have our TPTW CEO & Sales Team to seek audience with President Trump instead. I don't think Joe Biden will be officially inaugurated as President of the USA this January 20, 2021.
But that's just based on my OPINION. What do I know?
RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ) [UPDATED]
1/6/21 4:54 PM ET (GlobeNewswire)Print
Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) ("Rennova" or the "Company"), an owner and operator of rural hospitals in Tennessee, announces that on December 31. 2020, it completed an agreement with InnovaQor, Inc. (OTC: INOQ) (InnovaQor) a CO based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into InnovaQor. After closing these entities will operate as wholly owned subsidiaries of InnovaQor. Closing is subject to a number of customary conditions for a transaction of this nature and is intended to happen on or before January 31. 2021.
InnovaQor has previously completed a license agreement giving it certain rights to assets and technology from TPT Global Tech, Inc's. (OTC: TPTW) proprietary live streaming communication technology. As part of the License agreement InnovaQor and TPT have agreed a development project to create a next generation telehealth type platform. It is intended to combine the TPT and Rennova assets and technology into a smart phone and computer accessible healthcare platform to facilitate a patient's immediate access to healthcare and their local hospital or doctors office, for initial consultation, scheduling of appointments and follow on care and other added value services that may be one off or recurring.
InnovaQor has agreed to complete the necessary steps and SEC filings with the intent to facilitate TPT shareholders receiving approximately 2,500,000 shares in InnovaQor, and Rennova Health, Inc. shareholders receiving approximately $5M of Preference shares which will be converted to common shares. As described in the agreement TPT will retain direct ownership of a further 2,500,000 shares and Rennova will retain ownership of an additional $17.5M of Preference shares with certain conversion rights and restrictions, in InnovaQor. An additional 1,000,000 shares in InnovaQor will be allocated to TPT or its' assignees as an incentive to assist in product development.
"Rennova has previously disclosed its intention to separate its technology and software divisions. This agreement with InnovaQor finalizes these plans and the technology being contributed to the project by TPT creates an exciting opportunity to revolutionize the way patients access healthcare and continued aftercare", said Seamus Lagan, CEO of Rennova Health "We see first-hand the need our rural hospitals have to secure and retain patients. The product envisaged here will create immense value for many health care providers and provide a permanent solution to the current and probably extended reluctance of many people in the current pandemic to visit doctors' practices and hospitals for initial consultations. A phone based product that reduces a delay in access to healthcare and better manages ongoing care will save lives"
About Rennova Health, Inc.
Rennovaoperates three rural hospitals and a physician's office in Tennessee and a physician's office in Kentucky and provides industry-leading diagnostics and supportive software solutions to healthcare providers. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
No worry here... I am playing House Money.... FREE SHARES...
I sold few of my shares for profit and secure all my initial investment on this position. Thank you Lord.
Good Luck to all of us.
Go ZVTK!!!
Is TD Ameritrade level 2 platform (thinkorswim) is on a Delay activities transaction???
For the past two days it seems like it is on a DELAYED (not live) in showing or recording the transaction activities... would that be the case?
Thanks for your reply.
NEWS:
AABB - Asia Metals Inc. Acquires High Potential Gold and Base Metals Property In Prolific Mining Region of Mexico
Today 7:30 AM ET (GlobeNewswire)Print
Asia Broadband Inc. (AABB), through its wholly owned subsidiary Asia Metals Inc., announced today that it has acquired a high potential mineral property in the state of Colima, Mexico. The terms of the property purchase were a lump-sum payment of $1.1 million for a 100% interest in the 100 hectare parcel. The acquisition also allows for the opportunity to expand AABB's ownership footprint in the area. Previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property. The Company has initiated the construction of an exploration and development facility on the property to accelerate the process of moving toward production.
Located in a major iron-copper-gold production area, the property is approximately 25 kms east of the Pena Colorada mine in Minatitlan, Mexico. Advantageously located with direct access to main Highway #3, the property also has a natural water supply. Strategically viewed as a diversification acquisition, the Colima property is situated in a region where AABB has a comparative advantage of development resources and expertise readily available to rapidly develop the project.
AABB recently added a mine and property in Colombia to its portfolio and is continuing with its gold mine acquisition campaign targeting properties in South America, Central America and Mexico, which have high development potential and historic gold production. The focus of the campaign is to duplicate the successful acquisition model of the Company's existing high-density, shallow gold mine property in Guerrero, Mexico, that has known historical gold vein structures. AABB is currently directing a full-scale development and production expansion of its mine and property in Mexico.
Asia Broadband Inc. (OTC : AABB), through its wholly owned subsidiary Asia Metals Inc., is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets. The Company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Guerrero, Mexico, to our client sales networks in Asia. This vertical integration approach to sales transactions is the unique strength of Asia Broadband and differentiates the Company to its shareholders.
Contact the Company at:
Email: ir@asiabroadbandinc.com
Website: www.asiametalsinc.com
Phone: 702-866-9054
Parkin Investor Relations
Kevin Parkin
Forward-Looking Statements are contained in this press release within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the Asia Broadband Inc.'s (the "Company") expected current beliefs about the Company's business, which are subject to uncertainty and change. The operations and results of the Company could materially differ from what is expressed or implied by the statements made above when industry, regulatory, market and competitive circumstances change. Further information about these risks can be found in the annual and quarterly disclosures the Company has published on the OTC Markets website. The Company is under no obligation to update or alter its forward-looking statements as future circumstances, events and information may change.
__GNW8366DE3E__IMG
My Motto:
QUICK LAB TEST RESULTS = QUICK CHANCE OF RECOVERY!
https://www.cbs8.com/article/news/health/coronavirus/covid-19-quick-labs-mobile-rapid-testing-san-diego-company-tpt-med-tech/509-b95f718d-6186-4c16-a26f-a5db70e8876a
I like the HEADLINE....
RxAir Readying Rx3000 UV Light/HEPA Air Purifier FOR LARGE SCALE MANUFACTURING....
Let's go VYST....
NEWS:
RxAir Readying Rx3000 UV Light/HEPA Air Purifier for Large Scale Manufacturing
Today 8:15 AM ET (GlobeNewswire)Print
Vystar Corporation's (OTCQB: VYST) first new RxAir Rx3000 UV-C Light/HEPA Air Purifier prototypes made in the USA are now being assembled and tested under the direction of Strategic Link, Vystar's manufacturing management partner, as they take the final steps before mass production. The RxAir Rx3000 air purifier is an FDA Certified Class II medical device proven to destroy and remove 99.9% of airborne viruses, bacteria and particulates through extended exposure to high intensity germicidal UV-C light and HEPA filtration.
"Thanks to Strategic Links' robust supplier and manufacturing partner network and perseverance, we have been able to complete assembly and testing of the Rx3000 units 'Made in the USA' despite the COVID-related supply chains disruptions," stated Steven Rotman, President and CEO of Vystar Corp., owner of the RxAir product line. "Strategic Link had a monumental task of sourcing all suppliers and a U.S.-based ISO 13485-certified manufacturer in the midst of a pandemic. We are excited to take the final steps toward commercial production. Vystar is currently accepting applications for additional distributors to help meet the increasing COVID-related demand."
"With the Rx3000 from Scott Electronics approved, the next step will be to complete final recertifications and testing before turning on volume production," commented S.K Chan, President of Strategic Link. "We have provided substantial non-recurring engineering (NRE) services to ready the supply chain for commercial production and streamline manufacturing for an improved final product. We will coordinate with Vystar to scale capacity as appropriate."
"Scott Electronics and Strategic Link collaborated to help bring a better product to market in a very short period of time under difficult circumstances," stated Ken Morris, Scott Electronics General Manager. "Our team takes pride in the thought that we can be a small part of the solution to reduce the spread of infectious diseases."
Continual Improvement
"Strategic Link and its manufacturing partner Scott Electronics have an incredible engineering team that continually seeks to improve design, manufacture and performance of their clients' products," Rotman noted. "We are implementing their numerous recommendations to improve the performance and functionality of our existing products, and reviewing their concepts for future upgrades and accessories. As we learn more about COVID-19 and any other airborne pathogens that may emerge, we look forward to coordinating R&D efforts with them to always offer the best products to meet customers' ever-changing needs."
Since The Centers for Disease Control (CDC) on October 5, confirmed that COVID-19 can be transmitted via airborne means,and a group of U.S. scientists more strongly warned in the medical journal Science, that aerosols lingering in the air could be a major source of COVID-19 transmission, Vystar is seeing an uptick in demand for air purifiers.
Rx3000's FDA clearance as a Class II Medical Device allows for its use in hospitals and other healthcare facilities to reduce the risk of airborne disinfection.
"Continuous effective air disinfection in addition to following hygiene protocols and surface disinfection is critical because microscopic aerosolized viruses and bacteria expelled when people talk, breath, cough and sneeze will contaminate any disinfected room instantly," stated Dr. Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine Emeritus for Desert Regional Medical Center, and a member of Vystar Corp.'s Board of Directors. "Aerosolized viruses can hang in the air like smoke for hours waiting to infect one who inhales them.
"The major advantage of Rx3000 is that it continually swirls air past powerful germicidal UV-C lights for a high intensity dose that inactivates or kills more than 99.9% of airborne viruses, bacteria, mold and fungi and it traps those pathogens, plus airborne particulates, to reduce risk of infection and irritation," Stone added. "Rx3000's patented UV light 'kill chamber' makes it safer for users during HEPA filter changes as the viruses and bacteria caught in the filter are inactive or dead and unable to cause infection, versus active or live viruses and bacteria that may become dislodged and inhaled when changing filters in traditional air purifiers."
Testing in EPA-certified laboratories shows Rx3000 has been proven effective against harmful pathogens including multiple coronaviruses, H1N1, MRSA, pneumonia, strep, TB, measles, influenza, and the common cold and also neutralizes odors, indoor pollutants, and VOCs (volatile organic compounds). Each portable RxAir unit provides four to eight complete air changes per hour (ACH) for a 1500 to 3000 sq. ft. room to minimize risk of infection from airborne diseases for all in the room.
RxAir will begin taking deposits on Rx3000 pre-orders beginning Oct 18, 2020. For product and ordering information, visit www.RxAir.com.
For information on how to become an RxAir/Rx3000 distributor and/or bulk pricing, contact
Lee Howley, lhowley@vytex.com
Follow Vystar, Rx3000, RxAir and Vytex news on social media:
Twitter: @VystarCompany
#RxAir , #Coronavirus, #Covid, #UVLight, #UVdisinfection
Sources:
-- Kowalski, (2013, June) Residential Application of the RxAir UV light Portable Air Purification Unit, https://www.rxair.com/lab_results/residential-application/
-- Kowalski, (2009, Dec. 1) Prediction of Virus Inactivation by the UV 400, https://www.rxair.com/lab_results/virus-inactivation/
-- Kowalski, (2012, Jan20) Supplemental Air Purification for Hospitals and Health Care Facilities, https://www.rxair.com/lab_results/health-care-facilities/
-- Kowalski, Walsh, Petraitis (2020, March) 2020 COVID-19 Coronavirus Ultraviolet Susceptibility, https://www.researchgate.net/publication/339887436_2020_COVID-19_Coronavirus_Ultraviolet_Susceptibility, Accessed October 10, 2020
-- Coffey, Donavyn, Does UV light kill the new coronavirus?, (July 12, 2020) Live Science, https://www.livescience.com/uv-light-kill-coronavirus.html, (Accessed July 14, 2020)
-- Centers for Disease Control (2020, April 29) Decontamination & Reuse of Filtering Facepiece Respirators. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html. (Accessed July 21, 2020)
-- Centers for Disease Control (October 5, 2020) How Covid-19 Spreads: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html (Accessed Oct 9, 2020)
-- Prather K., Marr L., Schooley R. et al., Airborne transmission of SARS-CoV-2, Science, Oct. 5, 2020 doi: 10.1126/science.abf052,
https://science.sciencemag.org/content/early/2020/10/02/science.abf0521/tab-pdf (Accessed Oct. 9, 2020)
Financial Disclosure: Dr. Bryan Stone is a shareholder of Vystar Corp.
# # #
About Scott Electronics, Inc.
Scott Electronics, Inc, a family-owned business since 1986, is a total solution manufacturer for cable, harness, electromechanical and fiber optic assemblies. Headquartered in Salem, N.H., the company is ISO 9001 and ISO 13485 registered. For more information visit www.scottelec.com.
About Vystar Corporation:
Based in Worcester, Mass., Vystar Corp. (OTCQB: VYST) is the majority owner of Rotmans Furniture and Carpet and environmentally friendly technologies and products to improve lives, such as RxAir UV light air purification products, Vytex Natural Rubber Latex (NRL) and Fluid Energy Solutions. Vystar is the exclusive creator of Vytex, a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. For more information, visit www.vytex.com.
Contacts:
Vystar
Media: Julie Shepherd, Accentuate PR, 847 275 3643, Julie@accentuatepr.com
Investors: Lee Howley, lhowley@vytex.com 508-791-9114
Distributor Opportunities: Steve Rotman, CEO, lhowley@vytex.com 508-791-9114
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
Attachments
-- Vystar Corp
-- Vystar Corp
-- Vystar Corp
https://ml.globenewswire.com/media/7e4d1ec3-da41-490a-aa38-b76f8915752b/small/logo-jpg.jpg
Back to News Overview
Latest Headlines
My positionsMy watch listsAll News
RxAir Readying Rx3000 UV Light/HEPA Air Purifier for Large Scale
8:15 AM ET (GlobeNewswire)
AABB - Asia Metals Inc. Development Agreement for Gold-Backed CryptoCurrency
10/15/2020 (GlobeNewswire)
Verb Tech Names New CIO and New Chief Product Officer
10/13/2020 (Dow Jones)
More news from my portfolio...
More GlobeNewswire headlines
October 16, 2020
Noront Provides Gold and Nickel Exploration and Other Activities Update
8:05 AM ET (GlobeNewswire)
OMERS Infrastructure Announces Sale of Interest in Detroit River Tunnel
8:04 AM ET (GlobeNewswire)
ABM Creates Projected Savings of $7.8 Million for McKeesport Area School
8:01 AM ET (GlobeNewswire)
Medigus to Acquire Control of Automated Online & Offline Ticketing Platform
8:00 AM ET (GlobeNewswire)
NMI Holdings, Inc. to Host Virtual Investor Day on November 19, 2020
8:00 AM ET (GlobeNewswire)
More GlobeNewswire headlines...
News provided by , , , Copyright ©2020. All rights reserved.
Any recommendation, opinion or advice regarding securities or markets contai
I sold 250K of my shares @.065/share few weeks ago to get back my initial investment cost of 16.5k (for peace of mind).
I am now playing House Money - 750k free shares - already! That's not much I would like to have though, but, I am happy with it, rather than worry about it and hiding from my wife, constantly... avoiding the conversation of the ups and downs of the share price ....hahaha... LOL
THEREFORE, I have NO MORE FEAR.....The Shares Set Me Free!!!....
There are still Dividend coming, right?
Thank you guys.
Is there something wrong with TD Ameritrade> I could not sign in
I placed a BID for 450K shares of DBMM @.0025... using my TD Ameritrade account.... Just in case somebody's interested to sell some of their Position. Thanks and Good Luck.
Thanks for your opinion, whizknock... At least, now, I have better idea... I hope this situation work out well for all of us... Good luck to all.
Thank you for your opinion and suggestion. I wish I could be more active but I am a retired person already and living outside the USA .... back here in the Philippines. Good luck to all of us.
What if TMPS is awarded 50% of the total 5yrs US Navy Refueling Contract...based on what we least hope for and discussing for the past few months... THEN... went on as a Private Company instead of Reinstating their Status with the SEC... THEN... made us a low ball offer (i.e. $1.00/share) to buy-out our rights as existing share holders.... My Question is....
Do we all (share holders) need to be in a position to REJECT or ACCEPT the company' buy-out offer as one voice? IF so, what would be the FAIR MARKET Buy-Out Value for TMPS as of now given the assumption above do you think?
All Opinion is appreciated. Thank You.
Thank you for your reply and keen insight LOVE*PINK...I would never thought of considering a bid higher than what the asking price is in a normal scenario.... but, that's not the case here, right?... lol
So, how does this bidding works?
Do I have to announce that I am currently bidding for 500k @ .0016 limit (using my TD Ameritrade Acct.)?.... And hope that somebody match it? Would this be the case? Thanks
Question: Where and How big is their Indoor Cannabis facility IF they have any? Thanks
YES... you are pepe..lol
Thank you Skiluc for sharing your excellent DD to us too. Best wishes
Congratulation to ALL of us, Tony! Thank you for the DD.
WHY did Steve Rotman released the 8k without warning us... Now, I have to buy and accumulate shares on a much higher pps..... EVERY month.... just like EMA...... Oh, well, you can NOT win them all... BWAAAAAAAAAAAA.
Yes I know, BUT I like where the pps is trending right now. I can accumulate more shares every month.... and double or triple up my position by then.... LOL....Thanks
No, it's NOT okay with me. Let them have another three more months to complete whatever they need to do..... So long everything gets done before the year end is good to me - long term.... less tax to pay for capital gain.
No, it's NOT okay with me. Let them have another three more months to complete whatever they need to do..... So long everything gets done before the year end is good to me - long term.... less tax
QUOTE:.... Vystar Corporation @VystarCompany Jul 8
Hope everyone had a great 4th of July. We have been working hard gathering all the closing documents needed, 2 feet+ of paper between lease transfers - IP... Auditors have been in Worcester working on the 2-year audit the last 2 weeks & we should have an 8K filed shortly..... UNQUOTE.
How long do you think it will take Vystar to file the 8k" as promised-"Shortly".... another three months, perhaps?
Thanks
What's happening here? Why the sudden increase in volume - the last few days of trading? Are they changing the nature of their business model? Thanks
I believe, Official Announcement of the Closing of the "Consolidation" or what we call "Reverse Merger" will happen AFTER the closing bell, today. IMO
This will allow all the Shorts and EMA to have a very nice weekend to worry about.... hahaha
Thank you all for the replies... Sorry, I don't have PM... GLTA
Just to clarify again:
What happen if there's an actual Buyout before achieving the "strike price" of $3.44... will they pay the Warrant holders based on whatever the agreed Buyout Price per share... less whatever fees? Thanks
Thank you!!! Good luck
For clarification only - WARRANTS
You bought 1,000 shares of VERBW @ .75 current selling price. After a year, the PPS of the Warrant is now above the Strike Price of $3.44 and you want to Exercise the Warrants in exchange of actual shares....My question is.... Do still pay for whatever the Strike Price of $3.44/share + Broker's Fees?
Example:
Bought 1,000 x $ 0.75 = $ 750.00
1,000 x 3.44 Strike Price = $ 3,440.00 + Broker's Fee
You paid of a total cost of $ 4,190 + Broker's Fee
Would this be the case?
Thanks for your help and clarification.